Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Emerson v. Genocea Biosciences, Inc. et al
Case Number:
1:17-cv-12137
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
-
December 06, 2018
Genocea Beats Investor Claims It Hid Truth About Herpes Drug
A Massachusetts federal judge dismissed a proposed investor class action Thursday against Genocea Biosciences Inc., saying accusations that the company hid negative test results before announcing it could not finance ongoing trials for a genital herpes immunotherapy were not sufficiently supported for the case to proceed.
-
February 12, 2018
Investors In Genocea Herpes-Drug Row Get Lead Counsel
A Massachusetts federal judge on Monday tapped Scott & Scott Attorneys at Law LLP and Levi & Korsinsky LLP to guide investors who have accused Genocea Biosciences Inc. of hiding its inability to finance ongoing trials for a genital herpes immunotherapy and thus blindsiding them when deciding to halt its drug development plans.